Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Przeglądasz jako GOŚĆ

Wyszukujesz frazę ""Value in health: the journal of the International Society for Pharmacoeconomics and Outcomes Research [Value Health] NLMUID: 100883818"" wg kryterium: JN


Tytuł :
Integrating Alternative Social Value Judgments Into Cost-Effectiveness Analysis of Vaccines: An Application to Varicella-Zoster Virus Vaccination.
Autorzy :
Luyten J; Leuven Institute for Healthcare Policy, KULeuven, Kapucijnenvoer 35, 3000 Leuven, Belgium; Personal Social Services Research Unit, Department of Health Policy, London School of Economics, Houghton Street, London, England, United Kingdom.
van Hoek AJ; Department of Infectious Disease Epidemiology, Faculty of Epidemiology and Population Health, London School of Hygiene and Tropical Medicine, Keppel Street, London, England, United Kingdom; Centre for Infectious Diseases, National Institute for Public Health and the Environment, Antonie van Leeuwenhoeklaan, Bilthoven, The Netherlands. Electronic address: .
Pokaż więcej
Źródło :
Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research [Value Health] 2021 Jan; Vol. 24 (1), pp. 41-49. Date of Electronic Publication: 2020 Nov 14.
Typ publikacji :
Journal Article
Czasopismo naukowe
Tytuł :
Cost-Effectiveness of 4CMenB Infant Vaccination in England: A Comprehensive Valuation Considering the Broad Impact of Serogroup B Invasive Meningococcal Disease.
Autorzy :
Beck E; GSK, Value Evidence, Wavre, Belgium. Electronic address: .
Klint J; ICON plc, Stockholm, Sweden.
Neine M; Freelance C/O GSK, Wavre, Belgium.
Garcia S; Business & Decision Life Sciences C/O GSK, Wavre, Belgium.
Meszaros K; GSK, Value Evidence, Wavre, Belgium.
Pokaż więcej
Źródło :
Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research [Value Health] 2021 Jan; Vol. 24 (1), pp. 91-104. Date of Electronic Publication: 2020 Oct 28.
Typ publikacji :
Journal Article
Czasopismo naukowe
Tytuł :
Costs of Immunization Programs for 10 Vaccines in 94 Low- and Middle-Income Countries From 2011 to 2030.
Autorzy :
Sim SY; International Vaccine Access Center, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA; Department of International Health, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA. Electronic address: .
Watts E; International Vaccine Access Center, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA; Department of International Health, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA.
Constenla D; Department of International Health, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA; GlaxoSmithKline Plc., Panama City, Panama.
Huang S; International Vaccine Access Center, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA; Department of International Health, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA.
Brenzel L; Bill & Melinda Gates Foundation, Seattle, WA, USA.
Patenaude BN; International Vaccine Access Center, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA; Department of International Health, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA.
Pokaż więcej
Źródło :
Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research [Value Health] 2021 Jan; Vol. 24 (1), pp. 70-77. Date of Electronic Publication: 2020 Oct 31.
Typ publikacji :
Journal Article
Czasopismo naukowe
Tytuł :
Informing Global Cost-Effectiveness Thresholds Using Country Investment Decisions: Human Papillomavirus Vaccine Introductions in 2006-2018.
Autorzy :
Jit M; Department of Infectious Disease Epidemiology, Faculty of Epidemiology and Population Health, London School of Hygiene & Tropical Medicine, London, United Kingdom; Modelling and Economics Unit, National Infections Service, Public Health England, London, United Kingdom; School of Public Health, University of Hong Kong, Hong Kong SAR, China. Electronic address: .
Pokaż więcej
Źródło :
Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research [Value Health] 2021 Jan; Vol. 24 (1), pp. 61-66. Date of Electronic Publication: 2020 Oct 16.
Typ publikacji :
Journal Article
Czasopismo naukowe
Tytuł :
Examining Equity Effects of Health Interventions in Cost-Effectiveness Analysis: A Systematic Review.
Autorzy :
Avanceña ALV; Department of Health Management and Policy, School of Public Health, University of Michigan, Ann Arbor, Michigan, USA. Electronic address: .
Prosser LA; Department of Health Management and Policy, School of Public Health, University of Michigan, Ann Arbor, Michigan, USA; Susan B. Meister Child Health Evaluation and Research (CHEAR) Center, Department of Pediatrics, Medical School, University of Michigan, Ann Arbor, Michigan, USA.
Pokaż więcej
Źródło :
Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research [Value Health] 2021 Jan; Vol. 24 (1), pp. 136-143. Date of Electronic Publication: 2020 Dec 03.
Typ publikacji :
Journal Article; Review
Czasopismo naukowe
Tytuł :
Economic Evaluation of Vaccines: Belgian Reflections on the Need for a Broader Perspective.
Autorzy :
Annemans L; Department of Public Health and Primary Care, Ghent University, Ghent, Belgium. Electronic address: .
Beutels P; Centre for Health Economics Research and Modelling Infectious Diseases, Vaccine and Infectious Disease Institute, University of Antwerp, Antwerp, Belgium.
Bloom DE; Harvard T.H. Chan School of Public Health, Boston, MA, USA.
De Backer W; Department of Pneumology, University of Antwerp, Antwerp, Belgium.
Ethgen O; Department of Public Health, Epidemiology and Health Economics, Faculty of Medicine, University of Liège, Liège, Belgium.
Luyten J; Department of Public Health and Primary Care, Leuven Institute for Healthcare Policy, KU Leuven, Leuven, Belgium.
Van Wilder P; Université Libre de Bruxelles, School of Public Health, Brussels, Belgium.
Willem L; Centre for Health Economics Research and Modelling Infectious Diseases, Vaccine and Infectious Disease Institute, University of Antwerp, Antwerp, Belgium.
Simoens S; Department of Pharmaceutical and Pharmacological Sciences, KU Leuven, Leuven, Belgium.
Pokaż więcej
Źródło :
Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research [Value Health] 2021 Jan; Vol. 24 (1), pp. 105-111. Date of Electronic Publication: 2020 Dec 11.
Typ publikacji :
Journal Article
Czasopismo naukowe
Tytuł :
Replication of Randomized, Controlled Trials Using Real-World Data: What Could Go Wrong?
Autorzy :
Thompson D; Syneos Health, Boston, Massachusetts, USA. Electronic address: .
Pokaż więcej
Źródło :
Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research [Value Health] 2021 Jan; Vol. 24 (1), pp. 112-115. Date of Electronic Publication: 2020 Nov 20.
Typ publikacji :
Editorial
Opinia redakcyjna
Tytuł :
Cost-Effectiveness of Routine Childhood Vaccination Against Seasonal Influenza in Germany.
Autorzy :
Scholz SM; Immunization Unit, Robert Koch-Institute, Berlin, Germany; School of Public Health, Bielefeld University, Bielefeld, Germany. Electronic address: .
Weidemann F; Immunization Unit, Robert Koch-Institute, Berlin, Germany.
Damm O; School of Public Health, Bielefeld University, Bielefeld, Germany.
Ultsch B; Immunization Unit, Robert Koch-Institute, Berlin, Germany.
Greiner W; School of Public Health, Bielefeld University, Bielefeld, Germany.
Wichmann O; Immunization Unit, Robert Koch-Institute, Berlin, Germany.
Pokaż więcej
Źródło :
Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research [Value Health] 2021 Jan; Vol. 24 (1), pp. 32-40. Date of Electronic Publication: 2020 Nov 05.
Typ publikacji :
Journal Article
Czasopismo naukowe
Tytuł :
Economic Benefits of Immunization for 10 Pathogens in 94 Low- and Middle-Income Countries From 2011 to 2030 Using Cost-of-Illness and Value-of-Statistical-Life Approaches.
Autorzy :
Watts E; International Vaccine Access Center, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA; Department of International Health, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA. Electronic address: .
Sim SY; Department of Immunization, Vaccines and Biologicals (IVB), World Health Organization, Geneve, GE, CH.
Constenla D; GlaxoSmithKline Plc., Panama City, Panama.
Sriudomporn S; International Vaccine Access Center, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA; Department of International Health, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA.
Brenzel L; Bill & Melinda Gates Foundation, Seattle, WA, USA.
Patenaude B; International Vaccine Access Center, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA; Department of International Health, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA.
Pokaż więcej
Źródło :
Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research [Value Health] 2021 Jan; Vol. 24 (1), pp. 78-85. Date of Electronic Publication: 2020 Oct 17.
Typ publikacji :
Journal Article
Czasopismo naukowe
Tytuł :
Cost-Utility Analysis of a Complex Intervention to Reduce School-Based Bullying and Aggression: An Analysis of the Inclusive RCT.
Autorzy :
Legood R; London School of Hygiene & Tropical Medicine, Keppel Street, London, England, United Kingdom. Electronic address: .
Opondo C; London School of Hygiene & Tropical Medicine, Keppel Street, London, England, United Kingdom.
Warren E; London School of Hygiene & Tropical Medicine, Keppel Street, London, England, United Kingdom.
Jamal F; London School of Hygiene & Tropical Medicine, Keppel Street, London, England, United Kingdom.
Bonell C; London School of Hygiene & Tropical Medicine, Keppel Street, London, England, United Kingdom.
Viner R; UCL Great Ormond St. Institute of Child Health, 30 Guilford Street, London, England, United Kingdom.
Sadique Z; London School of Hygiene & Tropical Medicine, Keppel Street, London, England, United Kingdom.
Pokaż więcej
Źródło :
Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research [Value Health] 2021 Jan; Vol. 24 (1), pp. 129-135. Date of Electronic Publication: 2020 Sep 06.
Typ publikacji :
Journal Article
Czasopismo naukowe
Tytuł :
What We Know Now: An Economic Evaluation of Chickenpox Vaccination and Dose Timing Using an Agent-Based Model.
Autorzy :
Rafferty ERS; School of Public Health, University of Saskatchewan, Saskatoon, Saskatchewan, Canada; Faculty of Nursing, Edmonton Clinic Health Academy, University of Alberta, Edmonton, Alberta, Canada. Electronic address: .
McDonald W; Department of Computer Science, University of Saskatchewan, Saskatoon, Saskatchewan, Canada.
Osgood ND; Department of Computer Science, University of Saskatchewan, Saskatoon, Saskatchewan, Canada.
Doroshenko A; Faculty of Medicine and Dentistry, Department of Medicine, Division of Preventive Medicine, University of Alberta, Edmonton, Alberta, Canada.
Farag M; School of Public Health, University of Saskatchewan, Saskatoon, Saskatchewan, Canada; School of Public Administration and Development Economics, Doha Institute for Graduate Studies, Doha, Qatar.
Pokaż więcej
Źródło :
Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research [Value Health] 2021 Jan; Vol. 24 (1), pp. 50-60. Date of Electronic Publication: 2020 Nov 14.
Typ publikacji :
Journal Article
Czasopismo naukowe
Tytuł :
Cost-Effectiveness of Pediatric Influenza Vaccination in The Netherlands.
Autorzy :
de Boer PT; Unit of PharmacoTherapy, -Epidemiology, and -Economics (PTE2), Department of Pharmacy, University of Groningen, Groningen, The Netherlands. Electronic address: .
Nagy L; Unit of PharmacoTherapy, -Epidemiology, and -Economics (PTE2), Department of Pharmacy, University of Groningen, Groningen, The Netherlands.
Dolk FCK; ICON Health Economics and Epidemiology, Oxfordshire, United Kingdom.
Wilschut JC; Department of Medical Microbiology and Infection Prevention, University Medical Center Groningen, University of Groningen, Groningen, the Netherlands.
Pitman R; ICON Health Economics and Epidemiology, Oxfordshire, United Kingdom.
Postma MJ; Unit of PharmacoTherapy, -Epidemiology, and -Economics (PTE2), Department of Pharmacy, University of Groningen, Groningen, The Netherlands; Department of Health Sciences, University Medical Center Groningen, Groningen, The Netherlands; Department of Economics, Econometrics, and Finance, Faculty of Economics and Business, University of Groningen, Groningen, The Netherlands.
Pokaż więcej
Źródło :
Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research [Value Health] 2021 Jan; Vol. 24 (1), pp. 19-31. Date of Electronic Publication: 2020 Dec 11.
Typ publikacji :
Journal Article
Czasopismo naukowe
Tytuł :
Cost-Effectiveness Assessment of Monitoring Abiraterone Levels in Metastatic Castration-Resistant Prostate Cancer Patients.
Autorzy :
Ten Ham RMT; Division of Pharmacoepidemiology and Clinical Pharmacology, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, Utrecht, The Netherlands. Electronic address: .
van Nuland M; Department of Pharmacy & Pharmacology, The Netherlands Cancer Institute, Amsterdam, The Netherlands; Division of Pharmacology, The Netherlands Cancer Institute, Amsterdam, The Netherlands.
Vreman RA; Division of Pharmacoepidemiology and Clinical Pharmacology, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, Utrecht, The Netherlands.
de Graaf LG; Division of Pharmacoepidemiology and Clinical Pharmacology, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, Utrecht, The Netherlands.
Rosing H; Department of Pharmacy & Pharmacology, The Netherlands Cancer Institute, Amsterdam, The Netherlands.
Bergman AM; Division of Medical Oncology, The Netherlands Cancer Institute, Amsterdam, The Netherlands.
Huitema ADR; Department of Pharmacy & Pharmacology, The Netherlands Cancer Institute, Amsterdam, The Netherlands; Division of Pharmacology, The Netherlands Cancer Institute, Amsterdam, The Netherlands; Department of Clinical Pharmacy, University Medical Center Utrecht, Utrecht University, Utrecht, The Netherlands.
Beijnen JH; Division of Pharmacoepidemiology and Clinical Pharmacology, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, Utrecht, The Netherlands; Department of Pharmacy & Pharmacology, The Netherlands Cancer Institute, Amsterdam, The Netherlands; Division of Pharmacology, The Netherlands Cancer Institute, Amsterdam, The Netherlands.
Hövels AM; Division of Pharmacoepidemiology and Clinical Pharmacology, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, Utrecht, The Netherlands.
Pokaż więcej
Źródło :
Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research [Value Health] 2021 Jan; Vol. 24 (1), pp. 121-128. Date of Electronic Publication: 2020 Sep 11.
Typ publikacji :
Journal Article
Czasopismo naukowe
Tytuł :
What We Do Not Know About the Costs of Immunization Programs in Low- and Middle-Income Countries.
Autorzy :
Portnoy A; Center for Health Decision Science, Harvard T.H. Chan School of Public Health, Boston, MA, USA.
Resch SC; Center for Health Decision Science, Harvard T.H. Chan School of Public Health, Boston, MA, USA.
Suharlim C; Center for Health Decision Science, Harvard T.H. Chan School of Public Health, Boston, MA, USA; Management Sciences for Health, Boston, MA, USA.
Brenzel L; Bill & Melinda Gates Foundation, Seattle, WA, USA.
Menzies NA; Center for Health Decision Science, Harvard T.H. Chan School of Public Health, Boston, MA, USA; Department of Global Health and Population, Harvard T.H. Chan School of Public Health, Boston, MA, USA. Electronic address: .
Pokaż więcej
Źródło :
Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research [Value Health] 2021 Jan; Vol. 24 (1), pp. 67-69. Date of Electronic Publication: 2020 Nov 02.
Typ publikacji :
Journal Article
Czasopismo naukowe
Tytuł :
Consultations for Influenza-Like Illness in Primary Care in The Netherlands: A Regression Approach.
Autorzy :
Dolk FCK; Unit of Pharmacotherapy, Epidemiology, and Economics, Groningen Research Institute of Pharmacy, University of Groningen, Groningen, The Netherlands. Electronic address: .
de Boer PT; Unit of Pharmacotherapy, Epidemiology, and Economics, Groningen Research Institute of Pharmacy, University of Groningen, Groningen, The Netherlands.
Nagy L; ICON Health Economics and Epidemiology, Oxfordshire, UK.
Donker GA; NIVEL Primary Care Database - Sentinel Practices, Utrecht, The Netherlands.
Meijer A; Centre for Infectious Diseases Research, Diagnostics, and Laboratory Surveillance, National Institute for Public Health and the Environment, Bilthoven, The Netherlands.
Postma MJ; Unit of Pharmacotherapy, Epidemiology, and Economics, Groningen Research Institute of Pharmacy, University of Groningen, Groningen, The Netherlands; Department of Health Sciences, University Medical Center Groningen, Groningen, The Netherlands; Department of Economics, Econometrics, and Finance, Faculty of Economics and Business, University of Groningen, Groningen, The Netherlands.
Pitman R; ICON Health Economics and Epidemiology, Oxfordshire, UK.
Pokaż więcej
Źródło :
Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research [Value Health] 2021 Jan; Vol. 24 (1), pp. 11-18. Date of Electronic Publication: 2020 Dec 09.
Typ publikacji :
Journal Article
Czasopismo naukowe
Tytuł :
Health Economics of Vaccines: From Current Practice to Future Perspectives.
Autorzy :
Boersma C; Department of Health Sciences, University of Groningen, University Medical Center Groningen, The Netherlands; Department of Management Sciences, Open University The Netherlands, Heerlen, The Netherlands; Health-Ecore Ltd, Zeist, The Netherlands.
Postma MJ; Department of Health Sciences, University of Groningen, University Medical Center Groningen, The Netherlands; Health-Ecore Ltd, Zeist, The Netherlands; Department of Pharmacy, University of Groningen, Groningen, The Netherlands; Department of Economics, Econometrics and Finance, University of Groningen, Groningen, The Netherlands; Department of Pharmacology and Therapy, Universitas Airlangga, Surabaya, Indonesia; Center of Excellence in Higher Education for Pharmaceutical Care Innovation, Universitas Padjadjaran, Bandung, Indonesia. Electronic address: .
Pokaż więcej
Źródło :
Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research [Value Health] 2021 Jan; Vol. 24 (1), pp. 1-2. Date of Electronic Publication: 2020 Dec 14.
Typ publikacji :
Editorial
Opinia redakcyjna
Tytuł :
Distributional Cost-Effectiveness Analysis Comes of Age.
Autorzy :
Cookson R; Centre for Health Economics, University of York, York, England, UK. Electronic address: .
Griffin S; Centre for Health Economics, University of York, York, England, UK.
Norheim OF; Department of Global Public Health and Primary Care, University of Bergen, Norway.
Culyer AJ; Centre for Health Economics, University of York, York, England, UK.
Chalkidou K; Faculty of Medicine, School of Public Health, Imperial College London, London, England, UK.
Pokaż więcej
Źródło :
Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research [Value Health] 2021 Jan; Vol. 24 (1), pp. 118-120. Date of Electronic Publication: 2020 Nov 07.
Typ publikacji :
Journal Article
Czasopismo naukowe
Tytuł :
Cost-Effectiveness of Quadrivalent Versus Trivalent Influenza Vaccination in the Dutch National Influenza Prevention Program.
Autorzy :
Zeevat F; Department of Health Sciences, University of Groningen, University Medical Centre, Groningen, The Netherlands. Electronic address: .
Crépey P; Department of Quantitative Methods in Public Health, University of Rennes, Rennes, France.
Dolk FCK; Unit of PharmacoTherapy, Epidemiology, and Economics, University of Groningen, Department of Pharmacy, Groningen, The Netherlands.
Postma AJ; Asc Academics, Groningen, The Netherlands.
Breeveld-Dwarkasing VNA; Sanofi, Amsterdam, The Netherlands.
Postma MJ; Department of Health Sciences, University of Groningen, University Medical Centre, Groningen, The Netherlands; Unit of PharmacoTherapy, Epidemiology, and Economics, University of Groningen, Department of Pharmacy, Groningen, The Netherlands; Department of Economics, Econometrics, and Finance, University of Groningen, Faculty of Economics and Business, Groningen, The Netherlands.
Pokaż więcej
Źródło :
Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research [Value Health] 2021 Jan; Vol. 24 (1), pp. 3-10.
Typ publikacji :
Journal Article
Czasopismo naukowe
Tytuł :
Evaluating Vaccination Programs That Prevent Diseases With Potentially Catastrophic Health Outcomes: How Can We Capture the Value of Risk Reduction?
Autorzy :
Mauskopf J; RTI Health Solutions, Research Triangle Park, NC, USA. Electronic address: .
Masaquel C; RTI Health Solutions, San Jose, CA, USA.
Huang L; Pfizer Inc, Collegeville, PA, USA.
Pokaż więcej
Źródło :
Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research [Value Health] 2021 Jan; Vol. 24 (1), pp. 86-90. Date of Electronic Publication: 2020 Oct 13.
Typ publikacji :
Journal Article
Czasopismo naukowe
Tytuł :
Real-World Evidence: Understanding Sources of Variability Through Empirical Analysis.
Autorzy :
Crown WH; Florence Heller Graduate School, Brandeis University, Waltham, MA.
Bierer BE; Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA. Electronic address: .
Pokaż więcej
Źródło :
Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research [Value Health] 2021 Jan; Vol. 24 (1), pp. 116-117. Date of Electronic Publication: 2020 Dec 19.
Typ publikacji :
Editorial
Opinia redakcyjna

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies